CD44 and glioblastoma: Some of those commonly reported markers, though, include CD15, CD44, CD70, CD133, and EGFR.[31, 32, 33] Through primary and secondary antibody incubation with the glioblastoma organoids, only a handful of the surface markers were well expressed, like CD44, CD133, and EGFR.